Botulinum toxin injection for sialorrhea in Guillain-Barré syndrome: A case report

Key Points

• Sialorrhea improved significantly after botulinum toxin injection, demonstrating effective management.
• The patient experienced a notable reduction in drooling frequency and severity within weeks.
• Case report documents clinical outcomes following botulinum toxin administration in a Guillain-Barré syndrome patient.
• Findings highlight the potential of botulinum toxin as a treatment option for sialorrhea in this population.